CS logo
small CS logo
Centre Hospitalier Notre Dame - Reine Fabiola

Charleroi, Belgium
Hospital in Charleroi
Av. du Centenaire 73, 6061 Charleroi

About Centre Hospitalier Notre Dame - Reine Fabiola


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
4
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
3
Celgene
1
EBMT Solid Tumors Working Party
1
Eisai Inc.
1
Hoffmann-La Roche
1
Total Rows: 6

Clinical Trials at Centre Hospitalier Notre Dame - Reine Fabiola


During the past decade, Centre Hospitalier Notre Dame - Reine Fabiola conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
1998-03-01
Completed
554
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
1998-09-01
2007-09-01
Completed
Combination Chemotherapy in Treating Patients With Colorectal Cancer
2002-02-01
Completed
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
2002-08-01
Completed
552
E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer
2006-11-01
2013-06-01
Completed
762
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer
2006-09-01
2009-12-01
Completed
38

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centre Hospitalier Notre Dame - Reine Fabiola" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 3 trials sponsored, "Celgene" with 1 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Notre Dame - Reine Fabiola" #1 collaborator was "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "Eisai Limited" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEuropean Organisationfor Research andTreatment of Cancer -EORTC: 4European Organisationfor Research andTreatment of Cancer -EORTC: 4Cliniques universitairesSaint-Luc- UniversitéCatholique de Louvain:3Cliniques universitairesSaint-Luc- UniversitéCatholique de Louvain:3Celgene: 1Celgene: 1EBMT Solid TumorsWorking Party: 1EBMT Solid TumorsWorking Party: 1Eisai Inc.: 1Eisai Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsNCIC Clinical Trials Group: 2NCIC Clinical Trials Group: 2Australasian Leukaemiaand Lymphoma Group:1Australasian Leukaemiaand Lymphoma Group:1Breast International Group: 1Breast International Group: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1Eisai Limited: 1Eisai Limited: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Grup per l'Estudi delsLimfomes de Catalunyai Balears: 1Grup per l'Estudi delsLimfomes de Catalunyai Balears: 1Lymphoma Study Association: 1Lymphoma Study Association: 1Lymphoma Trials Office: 1Lymphoma Trials Office: 1Nordic Lymphoma Group: 1Nordic Lymphoma Group: 1

Clinical Trials Conditions at Centre Hospitalier Notre Dame - Reine Fabiola


According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Notre Dame - Reine Fabiola" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Hormone Resistant Prostate Cancer" (1 trials), "Lymphoma" (1 trials) and "Melanoma (Skin)" (1 trials). Many other conditions were trialed in "Centre Hospitalier Notre Dame - Reine Fabiola" in a lesser frequency.

Clinical Trials Intervention Types at Centre Hospitalier Notre Dame - Reine Fabiola


Most popular intervention types in "Centre Hospitalier Notre Dame - Reine Fabiola" are "Drug" (10 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (2 trials), "filgrastim" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Centre Hospitalier Notre Dame - Reine Fabiola


The vast majority of trials in "Centre Hospitalier Notre Dame - Reine Fabiola" are 6 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Centre Hospitalier Notre Dame - Reine Fabiola


Currently, there are NaN active trials in "Centre Hospitalier Notre Dame - Reine Fabiola". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre Hospitalier Notre Dame - Reine Fabiola, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier Notre Dame - Reine Fabiola, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1